2023年日本献血者、商业实验室和健康检查的大规模剩余样本中感染诱导的新冠病毒血清流行率比较
Comparison of Infection-Induced SARS-CoV-2 Seroprevalence Across Large-Scale Residual Samples From Blood Donors, Commercial Laboratories, and Health Checkups in Japan, 2023.
作者信息
Nishigaki Asuka, Kinoshita Ryo, Sakuraba Shoko, Sugihara Jun, Suzuki Tadaki, Suzuki Motoi, Yoneoka Daisuke
机构信息
National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
出版信息
Open Forum Infect Dis. 2025 Jul 17;12(8):ofaf415. doi: 10.1093/ofid/ofaf415. eCollection 2025 Aug.
We compared severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody seroprevalence using 3 types of residual blood samples simultaneously collected in November-December 2023 from blood donors, commercial laboratories, and health checkups. Overall seroprevalence ranged from 53.5% to 58.8%, and notable variations were observed among the 30-39 and 50-59 age groups, highlighting the importance of multisource seroepidemiological surveillance.
我们比较了2023年11月至12月同时从献血者、商业实验室和健康检查中收集的3种类型残余血样中的严重急性呼吸综合征冠状病毒2核衣壳抗体血清流行率。总体血清流行率在53.5%至58.8%之间，在30-39岁和50-59岁年龄组中观察到显著差异，凸显了多源血清流行病学监测的重要性。
Zotero 插件